Almac announced it has expanded its MHRA/FDA-approved UK commercial packaging facility with the acquisition of a state-of-the-art Noack N 623 blister packaging line from Romaco.
The acquisition comes in response to growing client demand for enhanced flexibility related to larger blister sizes and innovative multi unit blister formats, coupled to a requirement for non permeability and enhanced environmental protection, particularly product humidity control, the company said in a press release.
The highly flexible, cGMP-compliant technology can be configured to process both thermoform and cold form materials, with maximum blister sizes of 220mm x 155mm. With an automatic feeding system, filling inspection, and ejection station, and shorter set-up times, the line provides increased productivity, processing over 25,000 blisters per hour, including multi-product blisters.
“Blister size and dosage formats are becoming increasingly more complex. Additionally, product handling for innovative new molecules often requires enhanced environmental controls. This investment allows Almac, through its Pharma Services business unit, to offer this additional flexibility,” says Geoff Sloan, vp of manufacturing operations.
“Through this acquisition, coupled with our immanent entry into the US commercial packaging market, we continue to expand our capabilities and flexibility to meet our client’s needs.”
“The blister technology from Romaco Noack offers high OEE values and low lifecycle costs. Product changeovers are carried out easily and cleaning is quickly done. Our machines prove themselves flexible in operation and versatile in use,”, says Bernd Webel, sales director, Romaco.